|
HY-100620-5mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100620-50mg
|
MedChemexpress LLC
|
RPR121056 [CAS 181467-56-1]
|
|
Cancer-programmed cell death
|
|
|
HY-13255-100mg
|
MedChemexpress LLC
|
TAME [CAS 901-47-3]
|
|
Cancer-programmed cell death
|
|
|
HY-13255-50mg
|
MedChemexpress LLC
|
TAME [CAS 901-47-3]
|
|
Cancer-programmed cell death
|
|
|
HY-13255-1mL
|
MedChemexpress LLC
|
TAME [CAS 901-47-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-13255A-100mg
|
MedChemexpress LLC
|
TAME hydrochloride [CAS 1784-03-8]
|
|
Cancer-programmed cell death
|
|
|
HY-13255A-50mg
|
MedChemexpress LLC
|
TAME hydrochloride [CAS 1784-03-8]
|
|
Cancer-programmed cell death
|
|
|
HY-13255A-1mL
|
MedChemexpress LLC
|
TAME hydrochloride [CAS 1784-03-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-10mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-100mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-25mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-5mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-50mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
|
HY-116572A-1mL
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P72271-10ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
|
HY-P72271-2ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
|
HY-P72271-50ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
